Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2014-06-04 AGM Information
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
STADA Arzneimittel AG: STADA Executive Board shows satisfaction with financial year 2013 at Annual General Meeting and adheres to outlook for 2014
AGM Information Classification · 99% confidence The document explicitly mentions 'Annual General Meeting' multiple times, discusses the Chairman's speech at this meeting, and details resolutions passed, such as the dividend approval and confirmation of the Board. The filing header also includes 'Key word(s): AGM/EGM'. This strongly indicates the content relates to the proceedings or materials of the Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R).
2014-06-04 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states it is a 'Veröffentlichung einer Stimmrechtsmitteilung' (Publication of a voting rights notification). It details that Norges Bank and the Norwegian Ministry of Finance have notified the company that their voting rights share in STADA Arzneimittel AG has fallen below the 3% threshold, citing German securities law (§ 21 Abs. 1 WpHG). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The short length and nature of the announcement also confirm it is not a comprehensive report.
2014-06-02 German
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly states the total number of voting rights as of the end of May 2014 (60,443,900 Voting Rights). This content directly relates to the official results or status of shareholder voting rights, matching the definition for Declaration of Voting Results & Voting Rights Announcements (DVA). Although it is a short announcement, its specific subject matter overrides the general 'RPA' classification.
2014-05-30 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Veröffentlichung einer Stimmrechtsmitteilung' (Publication of a voting rights notification). It details changes in share ownership thresholds (crossing 3%) by BlackRock entities, referencing German securities law (§ 21 Abs. 1 WpHG). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes and related voting rights notifications.
2014-05-15 German
Q1 Report 2014
Interim / Quarterly Report Classification · 100% confidence The document provides detailed financial performance data, including consolidated interim management reports, sales development, and earnings development for the first quarter of 2014. It contains actual financial statements and substantive analysis for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). Q1 2014
2014-05-14 English
STADA Arzneimittel Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 04.06.2014 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 100% confidence The document is explicitly titled 'Einladung zur ordentlichen Hauptversammlung 2014' (Invitation to the Annual General Meeting 2014) and details the agenda ('Tagesordnung') for a meeting scheduled for June 4, 2014. The agenda includes standard AGM items like presenting the annual financial statements (TOP 1), voting on dividend allocation (TOP 2), and discharging board/supervisory members (TOP 3 & 4). This content directly relates to the Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2014-04-24 German

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.